Neurocrine Biosciences Inc. (NASDAQ: NBIX) made a huge leap in after-hours trading yesterday, as the company’s stock surged by 58.8 percent to $15.5 per share on 929,230 shares traded. NBIX stock is now 3.45 percent above its 50-day moving average and 17.81 percent below its 200-day moving average. Following the huge gain, Neurocrine Biosciences is 41.70 percent under its 52-week high and 20.79 percent above its 52-week low.
Also gaining double-digits was Convergys Corporation (NYSE: CVG), which rallied by 19.9 percent to $25 per share on 11,280 shares traded. Convergys’ stock is now 3.11 percent and 12.48 percent respectively above its 50-day and 200-day moving averages. The company is trading 2.52 percent below its 52-week high and 39.91 percent above its 52-week low.
CorMedix Inc. (NYSE: CRMD) was one of two companies making gains of between 8 and 9 percent in yesterday’s after-hours trading, as the company added 8.9 percent to $1.59 per share on 1,150 shares traded. CorMedix’s RSI is now 76.59, making the company’s stock overbought. CRMD stock is 66.90 percent above its 50-day moving average and 70.99 percent above its 200-day moving average. CorMedix is trading 4.58 percent below its 52-week peak and 204.17 percent above its 52-week low.
Not far behind was Spherix Inc. (NASDAQ: SPEX), which gained 8.3 percent to an even $9 per share on 1,770 shares traded. SPEX stock is 3.54 percent above its 50-day moving average and 0.28 percent below its 200-day moving average. The company is now 70.17 percent under its 52-week high and 104.18 percent above its 52-week low.
Cray Inc. (NASDAQ: CRAY) was fifth place among yesterday’s after-hours gainers, moving up by 7.1 percent to $29.1 per share on 26,520 shares traded. The company, which designs, develops, manufactures, markets and services “supercomputers” such as the Cray XE6 system, is now 15.27 percent above its 50-day moving average and 21.15 percent above its 200-day moving average. CRAY stock is 5 percent below its 52-week high and 76.25 percent above its 52-week low.
Three companies gained between 6 and 7 percent in yesterday’s after-hours trading, starting with AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), which is now at $12.08 per share on 2,600 shares traded after gaining 6.8 percent. ACRX is now 30.92 percent and 28.10 percent respectively above its 50-day and 200-day moving average.
Endocyte Inc. (NASDAQ: ECYT) was next, gaining 6.7 percent to $11.47 on 2,900 shares traded. The company is 1.60 percent above its 50-day moving average and 19.46 percent below its 200-day moving average.
LiqTech International Inc. (OTC: LIQT) added 6.6 percent to $2.26 per share on 1,400 shares traded, and is presently 15.11 percent below its 50-day moving average and 24.57 percent below its 200-day moving average.
The list of yesterday’s other notable gainers includes SearchMedia Holdings Ltd. (NYSE: IDI, up 5.7 percent to $1.48 per share), NF Energy Saving Corp. (OTC: NFEC, up 5.5 percent to $1.72), Zalicus Inc. (NASDAQ: ZLCS, up 5.5 percent to $1.34), Republic Airways Holdings Inc. (NASDAQ: RJET, up 5.5 percent to $11.6), RealD Inc. (NYSE: RLD, up 5.3 percent to $8.92), Verso Paper Corp. (NYSE: VRS, up 5.3 percent to $3.38, stock overbought as RSI at 95.67), and Perrigo Co. (NASDAQ: PRGO, up 5 percent to $160.59 per share).MGP Ingredients Inc. (NASDAQ: MGPI, down 2.4 percent to $5.26), and Vical Inc. (NASDAQ: VICL, down 2.4 percent to $1.23 per share).